Skip to content
StockMarketAgent
Sector pending / Social ServicesUpdated 2026-05-10 22:07 UTC

FRA/RH7 stock hub

FRA/RH7 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/RH7is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.1B
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/RH7FRA/RH7
—
Loading chart…
In the news

Latest news · FRA/RH7

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.7
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-13.4
P25 n/aP50 n/aP75 n/a
ROIC0.1
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/RH7 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
191
Groups with data
11
Currency
NZD
Showing 191 of 191 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
New Zealand
Country code
DE
Employees
7,700
Employees Change
500%
Employees Change Percent
6.94
Enterprise value
EUR 2B
Exchange
Frankfurt Stock Exchange
Financial currency
NZD
First seen
2026-05-10
Industry
Social Services
Last refreshed
2026-05-10
Market cap
EUR 1.1B
Price
EUR 1.09
Price currency
EUR
Rev Per Employee
51,828.77x
Sic
8300
Symbol
fra/RH7
Website
https://www.rymanhealthcare.co.nz

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

10
MetricValue
Earnings Yield
-24.35%
EV Earnings
-7.17x
EV/EBITDA
91.27x
EV/FCF
15.45x
EV/Sales
4.89x
FCF yield
11.3%
Forward P/E
18.72x
P/B ratio
0.56x
P/S ratio
2.87x
PE Ratio10 Y
19.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
0.93%
EBITDA Margin
4.88%
FCF margin
32.41%
Gross margin
6.55%
Gross Profit
EUR 26.1M
Gross Profit Growth
555.01%
Gross Profit Growth5 Y
6.03%
Net Income
EUR -278.8M
Pretax Margin
-52.59%
Profit Margin
-69.85%
Profit Per Employee
EUR -36,202
ROA
0.04
Roa5y
-0.06
ROCE
0.12
ROE
-13.37
Roe5y
6.01
ROIC
0.13
Roic5y
-0.19

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

19
MetricValue
Cagr10y
-12.24%
Cagr1y
-12.74%
Cagr3y
-27.63%
Cagr5y
-30.81%
Div CAGR10
3.31%
Div CAGR5
-7.81%
FCF Growth
-13.98%
FCF Growth Q
5.1%
FCF Growth3 Y
-8.03%
FCF Growth5 Y
3.63%
OCF Growth
-38.41%
OCF Growth Q
-33.78%
OCF Growth10 Y
1.05%
OCF Growth3 Y
-18.52%
OCF Growth5 Y
-12.89%
Revenue Growth
12.1x
Revenue Growth Q
13.23x
Revenue Growth3 Y
5.51x
Revenue Growth5 Y
6.78x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
EUR 0.06
Assets
EUR 6B
Cash
EUR 4.6M
Current Assets
EUR 98M
Current Liabilities
EUR 3.1B
Debt
EUR 838.5M
Debt EBITDA
EUR 39.2
Debt Equity
EUR 0.41
Debt FCF
EUR 6.48
Equity
EUR 2B
Interest Coverage
0.04
Liabilities
EUR 4B
Long Term Assets
EUR 5.9B
Long Term Liabilities
EUR 874M
Net Cash
EUR -833.8M
Net Cash By Market Cap
EUR -72.82
Net Debt EBITDA
EUR 42.82
Net Debt Equity
EUR 0.41
Net Debt FCF
EUR 6.45
Tangible Book Value
EUR 2B
Tangible Book Value Per Share
EUR 2.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.03
Inventory Turnover
799.4
Net Working Capital
EUR -2.9B
Quick ratio
0.01
Working Capital
EUR -2.9B
Working Capital Turnover
EUR -0.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-27.13%
Dividend per share
EUR 0
Last Dividend
EUR 0.05

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
10Y total return
-72.88%
1Y total return
-12.73%
200-day SMA
1.25
3Y total return
-62.1%
50-day SMA
1.07
50-day SMA vs 200-day SMA
50under200
5Y total return
-84.13%
All Time High
10.62
All Time High Change
-89.74%
All Time High Date
2019-12-30
All Time Low
0.93
All Time Low Change
17.27%
All Time Low Date
2026-04-13
ATR
0.04
Ch YTD
-22.7
High
1.09
High52
1.46
High52 Date
2025-12-19
High52ch
-25.09%
Low
1.09
Low52
0.93
Low52 Date
2026-04-13
Low52ch
17.27%
Ma50ch
1.68%
Price vs 200-day SMA
-12.52%
RSI
53.27
RSI Monthly
32.35
RSI Weekly
38.51
Sharpe ratio
-0.1x
Sortino ratio
-0.03
Total Return
-27.13%
Tr YTD
-22.7
Tr1m
6.86%
Tr1w
0.93%
Tr3m
-18.9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

3
MetricValue
Operating Income
EUR 3.7M
Operating Income Growth5 Y
34.09
Operating margin
0.93

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
986,949,375%
Net Borrowing
-494,796,293.7
Shares Insiders
2.74%
Shares Institutions
46.68%
Shares Qo Q
38.62%
Shares Yo Y
27.13%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

52
MetricValue
Adjusted FCF
EUR 128.2M
Average Volume
2,192.55x
Bv Per Share
2.01
CAPEX
EUR -29.8M
Ch10y
-79.34
Ch1m
6.86
Ch1w
0.93
Ch1y
-12.73
Ch3m
-18.9
Ch3y
-64.95
Ch5y
-86.76
Ch6m
-21.3
Change
-1%
Change From Open
0
Close
1.1
Days Gap
-1
Depreciation Amortization
16,122,512.8
Earnings Date
2026-05-26
EBIT
EUR 3.7M
EBITDA
EUR 19.5M
EPS
EUR -0.32
F Score
6
FCF
EUR 129.4M
FCF EV Yield
6.47x
Financing CF
-2,319,422
Fiscal Year End
March
Founded
1,984
Income Tax
EUR 68.9M
Investing CF
-163,602,062
Is Primary Listing
0
Last Earnings Date
2026-02-26
Last Report Date
2025-09-30
Ma150
1.26
Ma150ch
-13.56%
Ma20
1.04
Ma20ch
4.71%
Net CF
-6,751,185
Next Earnings Date
2026-05-26
Open
1.09
P FCF Ratio
8.85
P OCF Ratio
7.19
Ppne
521,151,724.4
Price Date
2026-05-08
Price EBITDA
EUR 58.8
Ptbv Ratio
0.56
Relative Volume
0.6x
Revenue
399,081,506x
SBC By Revenue
0.3x
Share Based Comp
1,201,474
Tax By Revenue
17.26x
Tr6m
-21.3%
Z Score
-0.07
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/RH7 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/RH7 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-12.7%
S&P 500 1Y: n/a
3Y total return
-62.1%
S&P 500 3Y: n/a
5Y total return
-84.1%
S&P 500 5Y: n/a
10Y total return
-72.9%
S&P 500 10Y: n/a
Ownership

Who owns FRA/RH7?

Insider, institutional, and short-interest positioning.

Institutional ownership
+46.7%
Share of float held by funds and institutions
Insider ownership
+2.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+27.1%
Negative means the company is buying back shares.
Technical

FRA/RH7 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
53.3
Neutral momentum band
Price vs 200-day MA
-12.5%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
-0.10
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/RH7

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/RH7 stock rating?

fra/RH7 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/RH7 analysis?

The full report lives at /stocks/fra/RH7/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/RH7?

The latest report frames fra/RH7 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/RH7 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.